这是一篇来自已证抗体库的有关人类 c-IAP2 (c-IAP2) 的综述，是根据23篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合c-IAP2 抗体。
c-IAP2 同义词: AIP1; API2; CIAP2; HAIP1; HIAP1; IAP-1; MALT2; MIHC; RNF49; c-IAP2

艾博抗（上海）贸易有限公司
domestic rabbit 单克隆（E40）
  • 免疫组化-石蜡切片; 人类; 1:50; 图 1a
  • 免疫印迹; 人类; 1:1000; 图 1d
艾博抗（上海）贸易有限公司c-IAP2抗体（Abcam, ab32059)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 1a) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 1d). Cell Death Dis (2017) ncbi
domestic rabbit 单克隆（E40）
  • 免疫组化-石蜡切片; 人类; 1:200; 图 3b
艾博抗（上海）贸易有限公司c-IAP2抗体（Abcam, E40)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 3b). Am J Physiol Gastrointest Liver Physiol (2015) ncbi
domestic rabbit 单克隆（E40）
  • proximity ligation assay; 人类; 图 s2
艾博抗（上海）贸易有限公司c-IAP2抗体（ABCAM, ab32059)被用于被用于proximity ligation assay在人类样本上 (图 s2). Oncotarget (2014) ncbi
亚诺法生技股份有限公司
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2
亚诺法生技股份有限公司c-IAP2抗体（Abnova, PAB0253)被用于被用于免疫印迹在人类样本上 (图 2). Oncotarget (2016) ncbi
赛默飞世尔
domestic rabbit 多克隆
  • 免疫印迹; 人类
赛默飞世尔c-IAP2抗体（Fisher, PAS-22997)被用于被用于免疫印迹在人类样本上. Oncotarget (2016) ncbi
赛信通（上海）生物试剂有限公司
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 6a
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling, 3130)被用于被用于免疫印迹在人类样本上 (图 6a). Oncogenesis (2021) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 s6a
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling, 3130)被用于被用于免疫印迹在人类样本上 (图 s6a). Sci Adv (2021) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell signaling, 3130)被用于被用于免疫印迹在人类样本上. Cell Commun Signal (2020) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 s5c
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling Technology, 3130)被用于被用于免疫印迹在人类样本上 (图 s5c). Cell (2019) ncbi
domestic rabbit 单克隆（58C7）
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling, 58C7)被用于. Sci Adv (2019) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 4c
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling, 3130P)被用于被用于免疫印迹在人类样本上 (图 4c). Mol Cell (2019) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 6e
赛信通（上海）生物试剂有限公司c-IAP2抗体（CST, 3130)被用于被用于免疫印迹在人类样本上 (图 6e). Cell Death Differ (2019) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 s12b
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling, #3130)被用于被用于免疫印迹在人类样本上 (图 s12b). Proc Natl Acad Sci U S A (2018) ncbi
domestic rabbit 单克隆（58C7）
  • 其他; 人类; 图 4c
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling, 3130)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 2a
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell signaling, 3130s)被用于被用于免疫印迹在人类样本上 (图 2a). Front Immunol (2016) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 3
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling, 3130)被用于被用于免疫印迹在人类样本上 (图 3). BMC Cancer (2016) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 s4b
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling, 3130)被用于被用于免疫印迹在人类样本上 (图 s4b). Cell Death Dis (2016) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 s6
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling Tech, 3130S)被用于被用于免疫印迹在人类样本上 (图 s6). Sci Signal (2016) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类; 图 8a
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signalling, 3130)被用于被用于免疫印迹在人类样本上 (图 8a). Oncotarget (2015) ncbi
domestic rabbit 单克隆（58C7）
  • 免疫印迹; 人类
赛信通（上海）生物试剂有限公司c-IAP2抗体（Cell Signaling Technologies, 3130)被用于被用于免疫印迹在人类样本上. PLoS Pathog (2015) ncbi
碧迪BD
小鼠 单克隆（F30-2285）
  • 免疫印迹; 人类; 1:250; 图 5b
碧迪BDc-IAP2抗体（BD Pharmigen, 552782)被用于被用于免疫印迹在人类样本上浓度为1:250 (图 5b). Sci Rep (2016) ncbi
小鼠 单克隆（F30-2285）
  • 其他; 人类; 图 st1
碧迪BDc-IAP2抗体（BD, F30-2285)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆（F30-2285）
  • 免疫印迹; 人类
碧迪BDc-IAP2抗体（BD Biosciences, 552782)被用于被用于免疫印迹在人类样本上. Oncogene (2014) ncbi
文章列表
  1. Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K, et al. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis. 2021;10:25 pubmed 出版商
  2. Kitamura Y, Kanaya N, Moleirinho S, Du W, Reinshagen C, Attia N, et al. Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers. Sci Adv. 2021;7: pubmed 出版商
  3. Lomphithak T, Choksi S, Mutirangura A, Tohtong R, Tencomnao T, Usubuchi H, et al. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma. Cell Commun Signal. 2020;18:161 pubmed 出版商
  4. Vredevoogd D, Kuilman T, Ligtenberg M, Boshuizen J, Stecker K, de Bruijn B, et al. Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold. Cell. 2019;178:585-599.e15 pubmed 出版商
  5. Kawalkowska J, Ogbechi J, Venables P, Williams R. cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs. Sci Adv. 2019;5:eaaw5422 pubmed 出版商
  6. Lee S, Mayr C. Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. Mol Cell. 2019;: pubmed 出版商
  7. Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J, et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155 pubmed 出版商
  8. Harper C, Woodcock D, Lam C, Garcia Albornoz M, Adamson A, Ashall L, et al. Temperature regulates NF-κB dynamics and function through timing of A20 transcription. Proc Natl Acad Sci U S A. 2018;115:E5243-E5249 pubmed 出版商
  9. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  10. Guicciardi M, Krishnan A, Bronk S, Hirsova P, Griffith T, Gores G. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell Death Dis. 2017;8:e2535 pubmed 出版商
  11. Ma W, Tummers B, van Esch E, Goedemans R, Melief C, Meyers C, et al. Human Papillomavirus Downregulates the Expression of IFITM1 and RIPK3 to Escape from IFN?- and TNF?-Mediated Antiproliferative Effects and Necroptosis. Front Immunol. 2016;7:496 pubmed
  12. Turner J, Kashyap T, Dawson J, Gomez J, Bauer A, Grant S, et al. XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma. Oncotarget. 2016;7:78896-78909 pubmed 出版商
  13. Hrgovic I, Doll M, Kleemann J, Wang X, Zoeller N, Pinter A, et al. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways. BMC Cancer. 2016;16:763 pubmed
  14. Klingbeil O, Lesche R, Gelato K, Haendler B, Lejeune P. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death Dis. 2016;7:e2365 pubmed 出版商
  15. Ananthula S, Sinha A, El Gassim M, Batth S, Marshall G, Gardner L, et al. Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers. Oncotarget. 2016;7:20869-89 pubmed 出版商
  16. Ranjan K, Pathak C. FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis. Sci Rep. 2016;6:22787 pubmed 出版商
  17. Kline C, van den Heuvel A, Allen J, Prabhu V, Dicker D, El Deiry W. ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases. Sci Signal. 2016;9:ra18 pubmed 出版商
  18. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  19. Zhang S, Schneider L, Vick B, Grunert M, Jeremias I, Menche D, et al. Anti-leukemic effects of the V-ATPase inhibitor Archazolid A. Oncotarget. 2015;6:43508-28 pubmed 出版商
  20. Greenfeld H, Takasaki K, Walsh M, Ersing I, Bernhardt K, Ma Y, et al. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation. PLoS Pathog. 2015;11:e1004890 pubmed 出版商
  21. Seidelin J, Larsen S, Linnemann D, Vainer B, Coskun M, Troelsen J, et al. Cellular inhibitor of apoptosis protein 2 controls human colonic epithelial restitution, migration, and Rac1 activation. Am J Physiol Gastrointest Liver Physiol. 2015;308:G92-9 pubmed 出版商
  22. Choi J, Park B, Chi S, Bae K, Kim S, Cho S, et al. HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization. Oncotarget. 2014;5:10084-99 pubmed
  23. He W, Wang Q, Srinivasan B, Xu J, Padilla M, Li Z, et al. A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy. Oncogene. 2014;33:3004-13 pubmed 出版商